Does BORTEZOMIB Cause Progressive multifocal leukoencephalopathy? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Progressive multifocal leukoencephalopathy have been filed in association with BORTEZOMIB (bortezomib). This represents 0.3% of all adverse event reports for BORTEZOMIB.
125
Reports of Progressive multifocal leukoencephalopathy with BORTEZOMIB
0.3%
of all BORTEZOMIB reports
42
Deaths
67
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From BORTEZOMIB?
Of the 125 reports, 42 (33.6%) resulted in death, 67 (53.6%) required hospitalization, and 19 (15.2%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for BORTEZOMIB.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which BORTEZOMIB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX